Literature DB >> 2180014

Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

R N Eisen1, P J Buckley, J Rosai.   

Abstract

Histochemical and immunohistochemical studies have been reported in only a few cases of sinus histiocytosis with massive lymphadenopathy (SHML) to date. These indicate that SHML cells belong to the macrophage/histiocyte family, but their exact origin is still unknown. We determined the antigenic phenotype of SHML cells in sections from 20 cases of routinely fixed, paraffin-embedded tissue and from two cases of fresh frozen tissue using a broad panel of antibodies to macrophage/histocyte, B-, and T-cell antigens. SHML cells expressed the following: (1) S-100 protein, (2) "pan-macrophage" antigens such as EBM11, HAM 56, and Leu-M3, (3) antigens functionally associated with phagocytosis (Fc receptor for IgG, complement receptor 3), and lysosomal activity (lysozyme, alpha 1-antichymotrypsin, and alpha 1-antitrypsyn), (4) antigens associated with early inflammation (Mac-387, 27E10), (5) antigens commonly found on monocytes, but not tissue macrophages (OKM5, Leu-M1), and (6) "activation" antigens (Ki-1 and receptors for transferrin and interleukin 2). These data suggest that SHML cells are true functionally activated macrophages that may be recently derived from circulating monocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180014

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  33 in total

1.  Rosai-Dorfman disease. Extranodal sinus histiocytosis in three co-existing sites. A case report.

Authors:  Misha Pless; Brian M Chang
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

2.  Primary intracerebral rosai-dorfman disease: a case report.

Authors:  S Natarajan; K D Post; J Strauchen; S Morgello
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

3.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): clinico-pathological study of three cases.

Authors:  Mercedes Bernácer-Borja; Miriam Blanco-Rodríguez; Jose Manuel Sanchez-Granados; Rocío Benitez-Fuentes; Alicia Cazorla-Jimenez; Carmen Rivas-Manga
Journal:  Eur J Pediatr       Date:  2006-04-19       Impact factor: 3.183

4.  Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case.

Authors:  M Paulli; F Locatelli; S Kindl; E Boveri; F Facchetti; F Porta; R Rosso; L Nespoli; U Magrini
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

5.  The rosai dorfman syndrome-the report of a rare case.

Authors:  Snehalatha R; Senthilnathan P; Prathiba Ramani; Sherlin J Herald
Journal:  J Clin Diagn Res       Date:  2013-05-10

Review 6.  Extranodal Rosai-Dorfman disease of bone, subcutaneous tissue and paranasal sinus mucosa with a review of its pathogenesis.

Authors:  Angela J Yoon; May Parisien; Frieda Feldman; Francis Young-In Lee
Journal:  Skeletal Radiol       Date:  2005-08-11       Impact factor: 2.199

7.  Rosai-Dorfman disease manifesting as intracranial and intraorbital lesion.

Authors:  Archana Hinduja; L Giselle Aguilar; Thomas Steineke; David Nochlin; Joseph C Landolfi
Journal:  J Neurooncol       Date:  2008-11-20       Impact factor: 4.130

8.  Radiotherapy for steroid-resistant laryngeal Rosai-Dorfman disease.

Authors:  D Toguri; A V Louie; K Rizkalla; J Franklin; G Rodrigues; V Venkatesan
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

9.  Inflammatory pseudotumour and Rosai-Dorfman disease of soft tissue: a histological continuum?

Authors:  D Govender; R Chetty
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

10.  Sinus histiocytosis with massive lymphadenopathy: a case report with pleural effusion and cervical lymphadenopathy.

Authors:  Jinyung Ju; Yong Soo Kwon; Kae Jung Jo; Dong Ryeol Chae; Jung Hwan Lim; Hee Jung Ban; Su Young Chi; In Jae Oh; Ku Sik Kim; Yu Il Kim; Young Chul Kim; Sung Chul Lim
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.